Download PDF
1 / Pages

Other users also viewed these articles

OP-3 ASSESSING TREATMENT ELIGIBILITY EXPANSION UNDER THE 2024 WHO GUIDELINES FOR CHRONIC HEPATITIS B Manuel Mendizabal; Constanza D Sabate; Esteban Gonzalez Ballerga; Fernando Gruz; Ezequiel Ridruejo; Alejandro Soza; Jaime Poniachik; Grace Vergara; Victoria Mainardi; Gabriel Mezzano; Fernando Bessone; Margarita Anders; Mario G Pessoa; Fernando Cairo; Nelia Hernandez; Melisa Dirchwolf; Hugo Cheinquer; Melina Susana; Luis Rondeau; Grabriel Rifrani; Herman Aguirre; Daniela Chiodi; Carla Enrique; Lucia Navarro; Eugenia Labaronnie; Patricia M Zitelli; Alexandre de Araujo; Antonella Olivetti; Daniela Simian; Diego Giunta; Marcelo Silva; Sebastian Marciano;
Ann Hepatol. 2024;29 Supl 3:
P-33 IMPACT OF SUSTAINED VIROLOGIC RESPONSE ON GLUCOSE PARAMETERS AMONG CHRONIC HEPATITIS C PATIENTS TREATED WITH DIRECT ACTING ANTIVIRALS Hugo Cheinquer; Fabia Benetti; Alexandre de Araujo; Italo de Maman; Cristina Cheinquer Coelho Borges; Fernando Wolff Herz;
Ann Hepatol. 2023;28 Supl 1:
P-2 HEPATIC STEATOSIS AMONG PEOPLE LIVING WITH HIV IN SOUTHERN BRAZIL: PREVALENCE AND RISK FACTORS Marina Ferri-Pezzini; Hugo Cheinquer; Alexandre de Araujo; Carlos T. Schmidt-Cerski; Eduardo Sprinz; Fernando Herz-Wolff; Julia Poeta;
Ann Hepatol. 2021;24 Supl 1: